Impact of Restricted Drug List Policy on Health Outcomes and Cost
About the Project
The focus of this study is the impact of different antipsychotic medication on the healthcare servcies utilization of adults with a serious mental illness and children with a severe emotional disturbance.
Principal Investigator |
|
Co-PI |
|
|
Funding Agency |
Bristol-Myers Squibb |
|
Award Amount |
$300,000 |
|
Dates |
12/10/2006 - 12/01/2008 |